Prognostic Value of Plasma Epstein–Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era

This study aimed to evaluate the prognostic value of plasma Epstein–Barr Virus DNA (EBV DNA) for local and regionally advanced nasopharyngeal carcinoma (NPC) patients treated with concurrent chemoradiotherapy in intensity-modulated radiotherapy (IMRT) era. In this observational study, 404 nonmetasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen-Hui, Tang, Lin-Quan, Guo, Shan-Shan, Chen, Qiu-Yan, Zhang, Lu, Liu, Li-Ting, Qian, Chao-Nan, Guo, Xiang, Xie, Dan, Zeng, Mu-Sheng, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748899/
https://www.ncbi.nlm.nih.gov/pubmed/26844482
http://dx.doi.org/10.1097/MD.0000000000002642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748899/
https://www.ncbi.nlm.nih.gov/pubmed/26844482
http://dx.doi.org/10.1097/MD.0000000000002642

Ejemplares similares